Patents by Inventor Young-Hee Kho

Young-Hee Kho has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anticancer composition comprising obovatol or obovatal
    Patent number: 8367736
    Abstract: Disclosed herein is an anticancer composition, comprising obovatol, represented by the following Chemical Formula 1, obovatal, represented by the following Chemical Formula 2, and/or pharmaceutical salts thereof. The composition exhibits the activity of inhibiting the growth of cancer cells and suppressing the expression and activity of matrix metalloproteinases (MMPs), and thus can be useful for the prophylaxis and treatment of cancer as well as for the inhibition of cancer metastasis.
    Type: Grant
    Filed: August 19, 2008
    Date of Patent: February 5, 2013
    Assignee: Korea Research Institute of Bioscience and Biotechnology
    Inventors: Byoung-Mog Kwon, Kwang-Hee Son, Dong-Cho Han, Su-Kyung Lee, Jung-Min Kim, Young-Hee Kho, Hyo-Kon Chun, Jae-Young Yang
  • Anticancer Composition Comprising Obovatol or Obovatal
    Publication number: 20080312337
    Abstract: Disclosed herein is an anticancer composition, comprising obovatol, represented by the following Chemical Formula 1, obovatal, represented by the following Chemical Formula 2, and/or pharmaceutical salts thereof. The composition exhibits the activity of inhibiting the growth of cancer cells and suppressing the expression and activity of matrix metalloproteinases (MMPs), and thus can be useful for the prophylaxis and treatment of cancer as well as for the inhibition of cancer metastasis.
    Type: Application
    Filed: August 19, 2008
    Publication date: December 18, 2008
    Applicant: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
    Inventors: Byoung-Mog KWON, Kwang-Hee SON, Dong-Cho HAN, Su-Kyung LEE, Jung-Min KIM, Young-Hee KHO, Hyo-Kon CHUN, Jae-Young YANG
  • Anticancer composition comprising obovatol or obovatal
    Publication number: 20070037889
    Abstract: Disclosed herein is an anticancer composition, comprising obovatol, represented by the following Chemical Formula 1, obovatal, represented by the following Chemical Formula 2, and/or pharmaceutical salts thereof. The composition exhibits the activity of inhibiting the growth of cancer cells and suppressing the expression and activity of matrix metalloproteinases (MMPs), and thus can be useful for the prophylaxis and treatment of cancer as well as for the inhibition of cancer metastasis.
    Type: Application
    Filed: August 7, 2006
    Publication date: February 15, 2007
    Applicant: Korea Research Institute of Bioscience and Biotechnology
    Inventors: Byoung-Mog Kwon, Kwang-Hee Son, Dong-Cho Han, Su-Kyung Lee, Jung-Min Kim, Young-Hee Kho, Hyo-Kon Chun, Jae-Young Yang